首页 > 最新文献

Critical care explorations最新文献

英文 中文
Preexisting Diabetes Mellitus and All-Cause Mortality in Adult Patients With Sepsis: A Population-Based Cohort Study. 成人败血症患者原有糖尿病与全因死亡率:一项基于人群的队列研究。
Q4 Medicine Pub Date : 2024-05-06 eCollection Date: 2024-05-01 DOI: 10.1097/CCE.0000000000001085
Federico Angriman, Jutamas Saoraya, Patrick R Lawler, Baiju R Shah, Claudio M Martin, Damon C Scales

Objectives: We assessed the association of preexisting diabetes mellitus with all-cause mortality and organ support receipt in adult patients with sepsis.

Design: Population-based cohort study.

Setting: Ontario, Canada (2008-2019).

Population: Adult patients (18 yr old or older) with a first sepsis-related hospitalization episode.

Interventions: None.

Measurements and main results: The main exposure of interest was preexisting diabetes (either type 1 or 2). The primary outcome was all-cause mortality by 90 days; secondary outcomes included receipt of invasive mechanical ventilation and new renal replacement therapy. We report adjusted (for baseline characteristics using standardization) risk ratios (RRs) alongside 95% CIs. A main secondary analysis evaluated the potential mediation by prior metformin use of the association between preexisting diabetes and all-cause mortality following sepsis. Overall, 503,455 adults with a first sepsis-related hospitalization episode were included; 36% had preexisting diabetes. Mean age was 73 years, and 54% of the cohort were females. Preexisting diabetes was associated with a lower adjusted risk of all-cause mortality at 90 days (RR, 0.81; 95% CI, 0.80-0.82). Preexisting diabetes was associated with an increased risk of new renal replacement therapy (RR, 1.53; 95% CI, 1.46-1.60) but not invasive mechanical ventilation (RR, 1.03; 95% CI, 1.00-1.05). Overall, 21% (95% CI, 19-28) of the association between preexisting diabetes and reduced risk of all-cause mortality was mediated by prior metformin use.

Conclusions: Preexisting diabetes is associated with a lower risk of all-cause mortality and higher risk of new renal replacement therapy among adult patients with sepsis. Future studies should evaluate the underlying mechanisms of these associations.

目的我们评估了脓毒症成人患者中既往糖尿病与全因死亡率和接受器官支持的关系:设计:基于人群的队列研究:地点:加拿大安大略省(2008-2019年):干预措施:无:干预措施:无:主要研究对象是既往患有糖尿病(1型或2型)的患者。主要结果是90天内的全因死亡率;次要结果包括接受有创机械通气和新的肾脏替代治疗。我们报告了调整后的风险比 (RRs) 和 95% CI。一项主要的二次分析评估了既往糖尿病与脓毒症后全因死亡率之间的关系是否可能受到二甲双胍的影响。研究共纳入了503455名首次接受败血症相关住院治疗的成年人,其中36%的人患有糖尿病。平均年龄为73岁,54%为女性。既往糖尿病与90天内全因死亡的调整后风险降低有关(RR,0.81;95% CI,0.80-0.82)。原有糖尿病与新的肾脏替代治疗风险增加有关(RR,1.53;95% CI,1.46-1.60),但与侵入性机械通气无关(RR,1.03;95% CI,1.00-1.05)。总体而言,21%(95% CI,19-28)的既往糖尿病与全因死亡风险降低之间的关系是由既往使用二甲双胍介导的:结论:既往糖尿病与脓毒症成人患者较低的全因死亡风险和较高的新肾脏替代治疗风险有关。未来的研究应评估这些关联的潜在机制。
{"title":"Preexisting Diabetes Mellitus and All-Cause Mortality in Adult Patients With Sepsis: A Population-Based Cohort Study.","authors":"Federico Angriman, Jutamas Saoraya, Patrick R Lawler, Baiju R Shah, Claudio M Martin, Damon C Scales","doi":"10.1097/CCE.0000000000001085","DOIUrl":"10.1097/CCE.0000000000001085","url":null,"abstract":"<p><strong>Objectives: </strong>We assessed the association of preexisting diabetes mellitus with all-cause mortality and organ support receipt in adult patients with sepsis.</p><p><strong>Design: </strong>Population-based cohort study.</p><p><strong>Setting: </strong>Ontario, Canada (2008-2019).</p><p><strong>Population: </strong>Adult patients (18 yr old or older) with a first sepsis-related hospitalization episode.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>The main exposure of interest was preexisting diabetes (either type 1 or 2). The primary outcome was all-cause mortality by 90 days; secondary outcomes included receipt of invasive mechanical ventilation and new renal replacement therapy. We report adjusted (for baseline characteristics using standardization) risk ratios (RRs) alongside 95% CIs. A main secondary analysis evaluated the potential mediation by prior metformin use of the association between preexisting diabetes and all-cause mortality following sepsis. Overall, 503,455 adults with a first sepsis-related hospitalization episode were included; 36% had preexisting diabetes. Mean age was 73 years, and 54% of the cohort were females. Preexisting diabetes was associated with a lower adjusted risk of all-cause mortality at 90 days (RR, 0.81; 95% CI, 0.80-0.82). Preexisting diabetes was associated with an increased risk of new renal replacement therapy (RR, 1.53; 95% CI, 1.46-1.60) but not invasive mechanical ventilation (RR, 1.03; 95% CI, 1.00-1.05). Overall, 21% (95% CI, 19-28) of the association between preexisting diabetes and reduced risk of all-cause mortality was mediated by prior metformin use.</p><p><strong>Conclusions: </strong>Preexisting diabetes is associated with a lower risk of all-cause mortality and higher risk of new renal replacement therapy among adult patients with sepsis. Future studies should evaluate the underlying mechanisms of these associations.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations Between Volume of Early Intravenous Fluid and Hospital Outcomes in Septic Patients With and Without Heart Failure: A Retrospective Cohort Study. 有心力衰竭和无心力衰竭的败血症患者早期静脉输液量与住院结果之间的关系:一项回顾性队列研究
Q4 Medicine Pub Date : 2024-04-26 eCollection Date: 2024-05-01 DOI: 10.1097/CCE.0000000000001082
Alexander J Beagle, Priya A Prasad, Colin C Hubbard, Sven Walderich, Sandra Oreper, Yumiko Abe-Jones, Margaret C Fang, Kirsten N Kangelaris

Objectives: To evaluate the relationship between early IV fluid volume and hospital outcomes, including death in-hospital or discharge to hospice, in septic patients with and without heart failure (HF).

Design: A retrospective cohort study using logistic regression with restricted cubic splines to assess for nonlinear relationships between fluid volume and outcomes, stratified by HF status and adjusted for propensity to receive a given fluid volume in the first 6 hours. An ICU subgroup analysis was performed. Secondary outcomes of vasopressor use, mechanical ventilation, and length of stay in survivors were assessed.

Setting: An urban university-based hospital.

Patients: A total of 9613 adult patients were admitted from the emergency department from 2012 to 2021 that met electronic health record-based Sepsis-3 criteria. Preexisting HF diagnosis was identified by the International Classification of Diseases codes.

Interventions: None.

Measurements and main results: There were 1449 admissions from patients with HF. The relationship between fluid volume and death or discharge to hospice was nonlinear in patients without HF, and approximately linear in patients with HF. Receiving 0-15 mL/kg in the first 6 hours was associated with lower likelihood of death or discharge to hospice compared with 30-45 mL/kg (odds ratio = 0.61; 95% CI, 0.41-0.90; p = 0.01) in HF patients, but no significant difference for non-HF patients. A similar pattern was identified in ICU admissions and some secondary outcomes. Volumes larger than 15-30 mL/kg for non-HF patients and 30-45 mL/kg for ICU-admitted non-HF patients were not associated with improved outcomes.

Conclusions: Early fluid resuscitation showed distinct patterns of potential harm and benefit between patients with and without HF who met Sepsis-3 criteria. Restricted cubic splines analysis highlighted the importance of considering nonlinear fluid outcomes relationships and identified potential points of diminishing returns (15-30 mL/kg across all patients without HF and 30-45 mL/kg when admitted to the ICU). Receiving less than 15 mL/kg was associated with better outcomes in HF patients, suggesting small volumes may be appropriate in select patients. Future studies may benefit from investigating nonlinear fluid-outcome associations and a focus on other conditions like HF.

目的评估伴有或不伴有心力衰竭(HF)的脓毒症患者早期静脉输液量与住院预后(包括院内死亡或出院后接受临终关怀)之间的关系:这是一项回顾性队列研究,采用限制性三次样条逻辑回归评估输液量与预后之间的非线性关系,根据心衰状态进行分层,并对前 6 小时接受特定输液量的倾向进行调整。还进行了 ICU 亚组分析。对幸存者使用血管加压素、机械通气和住院时间的次要结果进行了评估:背景:一家城市大学附属医院:2012年至2021年期间,急诊科共收治了9613名符合基于电子病历的败血症-3标准的成年患者。干预措施:无:干预措施:无:共有 1449 例高血压患者入院。无心房颤动患者的输液量与死亡或出院安宁疗护之间呈非线性关系,而心房颤动患者的输液量与死亡或出院安宁疗护之间呈近似线性关系。与 30-45 毫升/千克的输液量相比,前 6 小时内接受 0-15 毫升/千克输液的高血压患者死亡或出院安宁疗护的几率较低(几率比 = 0.61;95% CI,0.41-0.90;p = 0.01),但非高血压患者则无明显差异。在重症监护室入院和一些次要结果中也发现了类似的模式。非心房颤动患者的输液量大于 15-30 毫升/千克,入住 ICU 的非心房颤动患者的输液量大于 30-45 毫升/千克,均与预后改善无关:符合《败血症-3》标准的心房颤动患者和非心房颤动患者之间,早期液体复苏显示出不同的潜在危害和获益模式。限制性三次样条分析强调了考虑非线性液体结果关系的重要性,并确定了潜在的收益递减点(所有无 HF 患者为 15-30 mL/kg,入住 ICU 患者为 30-45 mL/kg)。接受少于 15 毫升/千克的输液与心房颤动患者更好的预后有关,这表明小容量输液可能适合特定患者。未来的研究可能会受益于对非线性液体-结果关联的调查以及对其他疾病(如心房颤动)的关注。
{"title":"Associations Between Volume of Early Intravenous Fluid and Hospital Outcomes in Septic Patients With and Without Heart Failure: A Retrospective Cohort Study.","authors":"Alexander J Beagle, Priya A Prasad, Colin C Hubbard, Sven Walderich, Sandra Oreper, Yumiko Abe-Jones, Margaret C Fang, Kirsten N Kangelaris","doi":"10.1097/CCE.0000000000001082","DOIUrl":"10.1097/CCE.0000000000001082","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the relationship between early IV fluid volume and hospital outcomes, including death in-hospital or discharge to hospice, in septic patients with and without heart failure (HF).</p><p><strong>Design: </strong>A retrospective cohort study using logistic regression with restricted cubic splines to assess for nonlinear relationships between fluid volume and outcomes, stratified by HF status and adjusted for propensity to receive a given fluid volume in the first 6 hours. An ICU subgroup analysis was performed. Secondary outcomes of vasopressor use, mechanical ventilation, and length of stay in survivors were assessed.</p><p><strong>Setting: </strong>An urban university-based hospital.</p><p><strong>Patients: </strong>A total of 9613 adult patients were admitted from the emergency department from 2012 to 2021 that met electronic health record-based Sepsis-3 criteria. Preexisting HF diagnosis was identified by the <i>International Classification of Diseases</i> codes.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>There were 1449 admissions from patients with HF. The relationship between fluid volume and death or discharge to hospice was nonlinear in patients without HF, and approximately linear in patients with HF. Receiving 0-15 mL/kg in the first 6 hours was associated with lower likelihood of death or discharge to hospice compared with 30-45 mL/kg (odds ratio = 0.61; 95% CI, 0.41-0.90; <i>p</i> = 0.01) in HF patients, but no significant difference for non-HF patients. A similar pattern was identified in ICU admissions and some secondary outcomes. Volumes larger than 15-30 mL/kg for non-HF patients and 30-45 mL/kg for ICU-admitted non-HF patients were not associated with improved outcomes.</p><p><strong>Conclusions: </strong>Early fluid resuscitation showed distinct patterns of potential harm and benefit between patients with and without HF who met Sepsis-3 criteria. Restricted cubic splines analysis highlighted the importance of considering nonlinear fluid outcomes relationships and identified potential points of diminishing returns (15-30 mL/kg across all patients without HF and 30-45 mL/kg when admitted to the ICU). Receiving less than 15 mL/kg was associated with better outcomes in HF patients, suggesting small volumes may be appropriate in select patients. Future studies may benefit from investigating nonlinear fluid-outcome associations and a focus on other conditions like HF.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140862572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intracranial Pressure and Cerebral Hemodynamics in Infants Before and After Glenn Procedure. 格伦手术前后婴儿的颅内压和脑血流动力学。
Q4 Medicine Pub Date : 2024-04-26 eCollection Date: 2024-05-01 DOI: 10.1097/CCE.0000000000001083
Abdulraouf M Z Jijeh, Anis Fatima, Mohammad A Faraji, Hussam K Hamadah, Ghassan A Shaath

Objectives: This prospective cohort study aimed to investigate changes in intracranial pressure (ICP) and cerebral hemodynamics in infants with congenital heart disease undergoing the Glenn procedure, focusing on the relationship between superior vena cava pressure and estimated ICP.

Design: A single-center prospective cohort study.

Setting: The study was conducted in a cardiac center over 4 years (2019-2022).

Patients: Twenty-seven infants with congenital heart disease scheduled for the Glenn procedure were included in the study, and detailed patient demographics and primary diagnoses were recorded.

Interventions: Transcranial Doppler (TCD) ultrasound examinations were performed at three time points: baseline (preoperatively), postoperative while ventilated (within 24-48 hr), and at discharge. TCD parameters, blood pressure, and pulmonary artery pressure were measured.

Measurements and main results: TCD parameters included systolic flow velocity, diastolic flow velocity (dFV), mean flow velocity (mFV), pulsatility index (PI), and resistance index. Estimated ICP and cerebral perfusion pressure (CPP) were calculated using established formulas. There was a significant postoperative increase in estimated ICP from 11 mm Hg (interquartile range [IQR], 10-16 mm Hg) to 15 mm Hg (IQR, 12-21 mm Hg) postoperatively (p = 0.002) with a trend toward higher CPP from 22 mm Hg (IQR, 14-30 mm Hg) to 28 mm Hg (IQR, 22-38 mm Hg) postoperatively (p = 0.1). TCD indices reflected alterations in cerebral hemodynamics, including decreased dFV and mFV and increased PI. Intracranial hemodynamics while on positive airway pressure and after extubation were similar.

Conclusions: Glenn procedure substantially increases estimated ICP while showing a trend toward higher CPP. These findings underscore the intricate interaction between venous pressure and cerebral hemodynamics in infants undergoing the Glenn procedure. They also highlight the remarkable complexity of cerebrovascular autoregulation in maintaining stable brain perfusion under these circumstances.

研究目的这项前瞻性队列研究旨在调查接受格伦手术的先天性心脏病婴儿的颅内压(ICP)和脑血流动力学的变化,重点关注上腔静脉压与估计ICP之间的关系:单中心前瞻性队列研究:研究在一家心脏中心进行,为期4年(2019-2022年):研究纳入了27名计划接受格伦手术的先天性心脏病婴儿,并详细记录了患者的人口统计学特征和主要诊断:在三个时间点进行了经颅多普勒(TCD)超声检查:基线(术前)、术后通气时(24-48 小时内)和出院时。对 TCD 参数、血压和肺动脉压力进行了测量:TCD 参数包括收缩期流速、舒张期流速 (dFV)、平均流速 (mFV)、搏动指数 (PI) 和阻力指数。估计的 ICP 和脑灌注压 (CPP) 采用既定公式计算。术后估计 ICP 明显增加,从 11 毫米汞柱(四分位数间距 [IQR],10-16 毫米汞柱)增至 15 毫米汞柱(四分位数间距,12-21 毫米汞柱)(p = 0.002),CPP 呈上升趋势,从 22 毫米汞柱(四分位数间距,14-30 毫米汞柱)增至 28 毫米汞柱(四分位数间距,22-38 毫米汞柱)(p = 0.1)。TCD 指数反映了脑血流动力学的改变,包括 dFV 和 mFV 下降以及 PI 上升。气道正压时和拔管后的颅内血流动力学相似:格伦手术大大增加了估计的 ICP,同时显示出更高的 CPP 趋势。这些发现强调了接受格伦手术的婴儿静脉压和脑血流动力学之间错综复杂的相互作用。这些研究结果强调了接受格伦手术的婴儿体内静脉压和脑血流动力学之间错综复杂的相互作用,同时也凸显了在这种情况下维持稳定脑灌注的脑血管自动调节的显著复杂性。
{"title":"Intracranial Pressure and Cerebral Hemodynamics in Infants Before and After Glenn Procedure.","authors":"Abdulraouf M Z Jijeh, Anis Fatima, Mohammad A Faraji, Hussam K Hamadah, Ghassan A Shaath","doi":"10.1097/CCE.0000000000001083","DOIUrl":"10.1097/CCE.0000000000001083","url":null,"abstract":"<p><strong>Objectives: </strong>This prospective cohort study aimed to investigate changes in intracranial pressure (ICP) and cerebral hemodynamics in infants with congenital heart disease undergoing the Glenn procedure, focusing on the relationship between superior vena cava pressure and estimated ICP.</p><p><strong>Design: </strong>A single-center prospective cohort study.</p><p><strong>Setting: </strong>The study was conducted in a cardiac center over 4 years (2019-2022).</p><p><strong>Patients: </strong>Twenty-seven infants with congenital heart disease scheduled for the Glenn procedure were included in the study, and detailed patient demographics and primary diagnoses were recorded.</p><p><strong>Interventions: </strong>Transcranial Doppler (TCD) ultrasound examinations were performed at three time points: baseline (preoperatively), postoperative while ventilated (within 24-48 hr), and at discharge. TCD parameters, blood pressure, and pulmonary artery pressure were measured.</p><p><strong>Measurements and main results: </strong>TCD parameters included systolic flow velocity, diastolic flow velocity (dFV), mean flow velocity (mFV), pulsatility index (PI), and resistance index. Estimated ICP and cerebral perfusion pressure (CPP) were calculated using established formulas. There was a significant postoperative increase in estimated ICP from 11 mm Hg (interquartile range [IQR], 10-16 mm Hg) to 15 mm Hg (IQR, 12-21 mm Hg) postoperatively (<i>p</i> = 0.002) with a trend toward higher CPP from 22 mm Hg (IQR, 14-30 mm Hg) to 28 mm Hg (IQR, 22-38 mm Hg) postoperatively (<i>p</i> = 0.1). TCD indices reflected alterations in cerebral hemodynamics, including decreased dFV and mFV and increased PI. Intracranial hemodynamics while on positive airway pressure and after extubation were similar.</p><p><strong>Conclusions: </strong>Glenn procedure substantially increases estimated ICP while showing a trend toward higher CPP. These findings underscore the intricate interaction between venous pressure and cerebral hemodynamics in infants undergoing the Glenn procedure. They also highlight the remarkable complexity of cerebrovascular autoregulation in maintaining stable brain perfusion under these circumstances.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial: Erratum 特利加压素在入住重症监护室的肝肾综合征-急性肾损伤患者中的作用:CONFIRM 试验的一项子研究:勘误
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1097/cce.0000000000001080
[This corrects the article DOI: 10.1097/CCE.0000000000000890.].
[此处更正了文章 DOI:10.1097/CCE.0000000000000890]。
{"title":"Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial: Erratum","authors":"","doi":"10.1097/cce.0000000000001080","DOIUrl":"https://doi.org/10.1097/cce.0000000000001080","url":null,"abstract":"[This corrects the article DOI: 10.1097/CCE.0000000000000890.].","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140775874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of Post-Intubation Laryngotracheal Stenosis With Respect to COVID-19 Status in a Large Multicenter Cohort Cross-Sectional Study 一项大型多中心队列横断面研究中与 COVID-19 状态有关的插管后喉气管狭窄风险
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1097/CCE.0000000000001081
Raluca Gray, P. M. Pradhan, Jesse Hoffmeister, S. Misono, Roy Cho, Christopher Tignanelli
OBJECTIVES: Occurrence of post-intubation laryngotracheal stenosis (LTS) with respect to COVID-19 status. DESIGN: Retrospective cross-sectional inpatient database. SETTING: Eleven Midwest academic and community hospitals, United States. PATIENTS: Adults, mechanically ventilated, from January 2020 to August 2022, who were subsequently readmitted within 6 months with a new diagnosis of LTS. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Six thousand eight hundred fifty-one COVID-19 negative and 1316 COVID-19 positive patients were intubated and had similar distribution by age (median 63.77 vs. 63.16 yr old), sex (male, 60.8%; n = 4173 vs. 60%; n = 789), endotracheal tube size (≥ 7.5, 75.8%; n = 5192 vs. 75.5%; n = 994), and comorbidities. The ICU length of stay (median [interquartile range (IQR)], 7.23 d [2.13–16.67 d] vs. 3.95 d [1.91–8.88 d]) and mechanical ventilation days (median [IQR], 5.57 d [1.01–14.18 d] vs. 1.37 d [0.35–4.72 d]) were longer in the COVID-19 positive group. The occurrence of LTS was double in the COVID-19 positive group (12.7%, n = 168 vs. 6.4%, n = 440; p < 0.001) and was most commonly diagnosed within 60 days of intubation. In multivariate analysis, the risk of LTS increased by 2% with each additional ICU day (hazard ratio [HR], 1.02; 95% CI, 1.02–1.03; p < 0.001), by 3% with each additional day of ventilation (HR, 1.03; 95% CI, 1.02–1.04; p < 0.001), and by 52% for each additional reintubation (HR, 1.52; 95% CI, 1.36–1.71; p < 0.001). We observed no significant association COVID-19 status and risk of LTS. CONCLUSIONS: The occurrence of post-intubation LTS was double in a COVID-19 positive cohort, with higher risk with increasing number of days intubated, days in the ICU and especially with the number of reintubations. COVID-19 status was not an independent risk factor for LTS.
目的:与 COVID-19 状态相关的插管后喉气管狭窄 (LTS) 发生率。设计:回顾性横断面住院患者数据库。地点:美国中西部 11 家学术和社区医院。患者:2020 年 1 月至 2022 年 8 月期间接受机械通气治疗的成人,随后在 6 个月内再次入院并被诊断为 LTS。干预:无。测量和主要结果:6815名COVID-19阴性患者和1316名COVID-19阳性患者接受了插管治疗,他们的年龄(中位数63.77岁 vs. 63.16岁)、性别(男性,60.8%;n = 4173 vs. 60%;n = 789)、气管导管大小(≥7.5,75.8%;n = 5192 vs. 75.5%;n = 994)和合并症分布相似。COVID-19阳性组的ICU住院时间(中位数[四分位距(IQR)],7.23 d [2.13-16.67 d] vs. 3.95 d [1.91-8.88 d])和机械通气天数(中位数[四分位距(IQR)],5.57 d [1.01-14.18 d] vs. 1.37 d [0.35-4.72 d])更长。COVID-19 阳性组的 LTS 发生率增加了一倍(12.7%,n = 168 vs. 6.4%,n = 440;p < 0.001),最常在插管后 60 天内确诊。在多变量分析中,ICU 每增加一天,LTS 风险增加 2%(危险比 [HR],1.02;95% CI,1.02-1.03;p < 0.001);每增加一天通气,LTS 风险增加 3%(HR,1.03;95% CI,1.02-1.04;p < 0.001);每增加一次重新插管,LTS 风险增加 52%(HR,1.52;95% CI,1.36-1.71;p < 0.001)。我们观察到 COVID-19 状态与 LTS 风险无明显关联。结论:在 COVID-19 阳性组群中,插管后 LTS 的发生率是原来的两倍,随着插管天数、重症监护室天数的增加,尤其是随着再次插管次数的增加,发生 LTS 的风险更高。COVID-19 状态并非 LTS 的独立风险因素。
{"title":"Risk of Post-Intubation Laryngotracheal Stenosis With Respect to COVID-19 Status in a Large Multicenter Cohort Cross-Sectional Study","authors":"Raluca Gray, P. M. Pradhan, Jesse Hoffmeister, S. Misono, Roy Cho, Christopher Tignanelli","doi":"10.1097/CCE.0000000000001081","DOIUrl":"https://doi.org/10.1097/CCE.0000000000001081","url":null,"abstract":"OBJECTIVES: Occurrence of post-intubation laryngotracheal stenosis (LTS) with respect to COVID-19 status. DESIGN: Retrospective cross-sectional inpatient database. SETTING: Eleven Midwest academic and community hospitals, United States. PATIENTS: Adults, mechanically ventilated, from January 2020 to August 2022, who were subsequently readmitted within 6 months with a new diagnosis of LTS. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Six thousand eight hundred fifty-one COVID-19 negative and 1316 COVID-19 positive patients were intubated and had similar distribution by age (median 63.77 vs. 63.16 yr old), sex (male, 60.8%; n = 4173 vs. 60%; n = 789), endotracheal tube size (≥ 7.5, 75.8%; n = 5192 vs. 75.5%; n = 994), and comorbidities. The ICU length of stay (median [interquartile range (IQR)], 7.23 d [2.13–16.67 d] vs. 3.95 d [1.91–8.88 d]) and mechanical ventilation days (median [IQR], 5.57 d [1.01–14.18 d] vs. 1.37 d [0.35–4.72 d]) were longer in the COVID-19 positive group. The occurrence of LTS was double in the COVID-19 positive group (12.7%, n = 168 vs. 6.4%, n = 440; p < 0.001) and was most commonly diagnosed within 60 days of intubation. In multivariate analysis, the risk of LTS increased by 2% with each additional ICU day (hazard ratio [HR], 1.02; 95% CI, 1.02–1.03; p < 0.001), by 3% with each additional day of ventilation (HR, 1.03; 95% CI, 1.02–1.04; p < 0.001), and by 52% for each additional reintubation (HR, 1.52; 95% CI, 1.36–1.71; p < 0.001). We observed no significant association COVID-19 status and risk of LTS. CONCLUSIONS: The occurrence of post-intubation LTS was double in a COVID-19 positive cohort, with higher risk with increasing number of days intubated, days in the ICU and especially with the number of reintubations. COVID-19 status was not an independent risk factor for LTS.","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140770179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First-Line Respiratory Support for Children With Hematologic Malignancy and Acute Respiratory Failure 为患有血液恶性肿瘤和急性呼吸衰竭的儿童提供一线呼吸支持
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1097/CCE.0000000000001076
Hassaan Asif, Jennifer L. McNeer, Nancy S. Ghanayem, John F. Cursio, Jason M. Kane
OBJECTIVES: To characterize trends in noninvasive ventilation (NIV) and invasive mechanical ventilation (IMV) use over time in children with hematologic malignancy admitted to the PICU with acute respiratory failure (ARF), and to identify risk factors associated with NIV failure requiring transition to IMV. DESIGN: Retrospective cohort analysis using the Virtual Pediatric Systems (VPS, LLC) between January 1, 2010 and December 31, 2019. SETTING: One hundred thirteen North American PICUs participating in VPS. PATIENTS: Two thousand four hundred eighty children 0–21 years old with hematologic malignancy admitted to participating PICUs for ARF requiring respiratory support. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: There were 3013 total encounters, of which 868 (28.8%) received first-line NIV alone (NIV only), 1544 (51.2%) received first-line IMV (IMV only), and 601 (19.9%) required IMV after a failed NIV trial (NIV failure). From 2010 to 2019, the NIV only group increased from 9.6% to 43.1% and the IMV only group decreased from 80.1% to 34.2% (p < 0.001). The NIV failure group had the highest mortality compared with NIV only and IMV only (36.6% vs. 8.1%, vs. 30.5%, p < 0.001). However, risk-of-mortality (ROM) was highest in the IMV only group compared with NIV only and NIV failure (median Pediatric Risk of Mortality III ROM 8.1% vs. 2.8% vs. 5.5%, p < 0.001). NIV failure patients also had the longest median PICU length of stay compared with the other two study groups (15.2 d vs. 6.1 and 9.0 d, p < 0.001). Higher age was associated with significantly decreased odds of NIV failure, and diagnosis of non-Hodgkin lymphoma was associated with significantly increased odds of NIV failure compared with acute lymphoid leukemia. CONCLUSIONS: For children with hematologic malignancy admitted to the PICU with ARF, NIV has replaced IMV as the most common initial therapy. NIV failure rate remains high with high-observed mortality despite lower PICU admission ROM.
目的描述因急性呼吸衰竭(ARF)入住 PICU 的血液系统恶性肿瘤患儿使用无创通气(NIV)和有创机械通气(IMV)随时间推移的趋势,并确定与 NIV 失败需要转为 IMV 相关的风险因素。设计:使用虚拟儿科系统(VPS,LLC)对 2010 年 1 月 1 日至 2019 年 12 月 31 日期间的情况进行回顾性队列分析。设置:参与 VPS 的 113 个北美 PICU。患者:2,480名0-21岁血液系统恶性肿瘤患儿,因ARF需要呼吸支持而入住参与计划的PICU。干预:无。测量和主要结果:共有 3013 次就诊,其中 868 人(28.8%)仅接受了一线 NIV(仅 NIV),1544 人(51.2%)接受了一线 IMV(仅 IMV),601 人(19.9%)在 NIV 试验失败后需要 IMV(NIV 失败)。从 2010 年到 2019 年,仅 NIV 组从 9.6% 增加到 43.1%,仅 IMV 组从 80.1% 下降到 34.2%(p < 0.001)。与仅使用 NIV 和仅使用 IMV 相比,NIV 失败组的死亡率最高(36.6% vs. 8.1%, vs. 30.5%,p < 0.001)。然而,与仅使用 NIV 和 NIV 失败组相比,仅使用 IMV 组的死亡风险 (ROM) 最高(中位儿科死亡风险 III ROM 8.1% vs. 2.8% vs. 5.5%,p < 0.001)。与其他两个研究组相比,NIV失败患者的PICU住院时间中位数也最长(15.2天 vs. 6.1天和9.0天,p < 0.001)。与急性淋巴细胞白血病相比,年龄越大发生 NIV 失败的几率越低;与非霍奇金淋巴瘤相比,诊断为非霍奇金淋巴瘤发生 NIV 失败的几率明显增加。结论:对于因急性淋巴细胞白血病入住 PICU 的血液恶性肿瘤患儿,NIV 已取代 IMV 成为最常见的初始疗法。尽管PICU入院ROM较低,但NIV失败率仍然很高,死亡率也很高。
{"title":"First-Line Respiratory Support for Children With Hematologic Malignancy and Acute Respiratory Failure","authors":"Hassaan Asif, Jennifer L. McNeer, Nancy S. Ghanayem, John F. Cursio, Jason M. Kane","doi":"10.1097/CCE.0000000000001076","DOIUrl":"https://doi.org/10.1097/CCE.0000000000001076","url":null,"abstract":"OBJECTIVES: To characterize trends in noninvasive ventilation (NIV) and invasive mechanical ventilation (IMV) use over time in children with hematologic malignancy admitted to the PICU with acute respiratory failure (ARF), and to identify risk factors associated with NIV failure requiring transition to IMV. DESIGN: Retrospective cohort analysis using the Virtual Pediatric Systems (VPS, LLC) between January 1, 2010 and December 31, 2019. SETTING: One hundred thirteen North American PICUs participating in VPS. PATIENTS: Two thousand four hundred eighty children 0–21 years old with hematologic malignancy admitted to participating PICUs for ARF requiring respiratory support. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: There were 3013 total encounters, of which 868 (28.8%) received first-line NIV alone (NIV only), 1544 (51.2%) received first-line IMV (IMV only), and 601 (19.9%) required IMV after a failed NIV trial (NIV failure). From 2010 to 2019, the NIV only group increased from 9.6% to 43.1% and the IMV only group decreased from 80.1% to 34.2% (p < 0.001). The NIV failure group had the highest mortality compared with NIV only and IMV only (36.6% vs. 8.1%, vs. 30.5%, p < 0.001). However, risk-of-mortality (ROM) was highest in the IMV only group compared with NIV only and NIV failure (median Pediatric Risk of Mortality III ROM 8.1% vs. 2.8% vs. 5.5%, p < 0.001). NIV failure patients also had the longest median PICU length of stay compared with the other two study groups (15.2 d vs. 6.1 and 9.0 d, p < 0.001). Higher age was associated with significantly decreased odds of NIV failure, and diagnosis of non-Hodgkin lymphoma was associated with significantly increased odds of NIV failure compared with acute lymphoid leukemia. CONCLUSIONS: For children with hematologic malignancy admitted to the PICU with ARF, NIV has replaced IMV as the most common initial therapy. NIV failure rate remains high with high-observed mortality despite lower PICU admission ROM.","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140774741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Update on Gender Disparity in Critical Care Conferences 重症监护会议中的性别差异最新情况
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1097/CCE.0000000000001075
Laura-Anne Dymore-Brown, Amrit Ahluwalia, Carole Dangoisse, Faryal Zaman, Jariya Sereeyotin, Sangeeta Mehta, Victoria Metaxa
This commentary’s objective was to identify whether female representation at critical care conferences has improved since our previous publication in 2018. We audited the scientific programs from three international (International Symposium on Intensive Care and Emergency Medicine [ISICEM], European Society of Intensive Care Medicine [ESICM], and Society of Critical Care Medicine [SCCM]) and two national (State of the Art [SOA] and Critical Care Canada Forum) critical care conferences from the years 2017 to 2022. We collected data on the number of female faculty members and categorized them into physicians, nurses, allied health professions (AHPs), and other. Across all conferences, there was an increased representation of females as speakers and moderators over the 6 years. However, at each conference, male speakers outnumbered female speakers. Only two conferences achieved gender parity in speakers, SCCM in 2021 (48% female) and 2022 and SOA in 2022 (48% female). These conferences also had the highest representation of female nursing and AHP speakers (25% in SCCM, 2021; 19% in SOA, 2022). While there was a statistically significant increase in female speakers (p < 0.01) in 2022 compared with 2016, there was a persistent gender gap in the representation of men and female physicians. While the proportion of female moderators increased in each conference every year, the increase was statistically only significant for ISICEM, ESICM, and SCCM (p < 0.05). The proportion of female nurses and AHP speakers increased in 2022 compared with 2016 (p < 0.0001) but their overall representation was low with the highest proportion (25%) in the 2022 SCCM conference and the lowest (0.5%) in the 2017 ISICEM conference. This follow-up study demonstrates a narrowing but persisting gender gap in the studied critical care conferences. Thus, a commitment toward minimizing gender inequalities is warranted.
本评论的目的是确定自 2018 年发表上一篇文章以来,女性在重症监护会议中的代表性是否有所改善。我们审核了 2017 年至 2022 年期间三个国际性(国际重症监护和急诊医学研讨会 [ISICEM]、欧洲重症监护医学会 [ESICM] 和重症监护医学会 [SCCM])和两个全国性(艺术现状 [SOA] 和加拿大重症监护论坛)重症监护会议的科学计划。我们收集了女性教员人数的数据,并将她们分为医生、护士、专职医疗人员(AHPs)和其他人员。在所有会议中,女性发言人和主持人的人数在这 6 年中有所增加。不过,在每次会议上,男性发言人的人数都多于女性发言人。只有两个会议的发言人实现了性别均等,分别是 2021 年(48% 为女性)和 2022 年的 SCCM 以及 2022 年的 SOA(48% 为女性)。在这些会议上,女性护理人员和 AHP 发言者的比例也最高(2021 年 SCCM 为 25%;2022 年 SOA 为 19%)。虽然与 2016 年相比,2022 年女性发言人的比例有了统计学意义上的显著提高(p < 0.01),但男女医生的代表比例仍存在性别差距。虽然女性主持人的比例在每个会议上都逐年增加,但在统计学上只有 ISICEM、ESICM 和 SCCM 有显著增加(p < 0.05)。与 2016 年相比,2022 年女护士和 AHP 发言者的比例有所增加(p < 0.0001),但她们的总体比例较低,2022 年 SCCM 会议的比例最高(25%),2017 年 ISICEM 会议的比例最低(0.5%)。这项跟踪研究表明,在所研究的重症监护会议中,性别差距正在缩小,但持续存在。因此,有必要致力于将性别不平等降至最低。
{"title":"An Update on Gender Disparity in Critical Care Conferences","authors":"Laura-Anne Dymore-Brown, Amrit Ahluwalia, Carole Dangoisse, Faryal Zaman, Jariya Sereeyotin, Sangeeta Mehta, Victoria Metaxa","doi":"10.1097/CCE.0000000000001075","DOIUrl":"https://doi.org/10.1097/CCE.0000000000001075","url":null,"abstract":"This commentary’s objective was to identify whether female representation at critical care conferences has improved since our previous publication in 2018. We audited the scientific programs from three international (International Symposium on Intensive Care and Emergency Medicine [ISICEM], European Society of Intensive Care Medicine [ESICM], and Society of Critical Care Medicine [SCCM]) and two national (State of the Art [SOA] and Critical Care Canada Forum) critical care conferences from the years 2017 to 2022. We collected data on the number of female faculty members and categorized them into physicians, nurses, allied health professions (AHPs), and other. Across all conferences, there was an increased representation of females as speakers and moderators over the 6 years. However, at each conference, male speakers outnumbered female speakers. Only two conferences achieved gender parity in speakers, SCCM in 2021 (48% female) and 2022 and SOA in 2022 (48% female). These conferences also had the highest representation of female nursing and AHP speakers (25% in SCCM, 2021; 19% in SOA, 2022). While there was a statistically significant increase in female speakers (p < 0.01) in 2022 compared with 2016, there was a persistent gender gap in the representation of men and female physicians. While the proportion of female moderators increased in each conference every year, the increase was statistically only significant for ISICEM, ESICM, and SCCM (p < 0.05). The proportion of female nurses and AHP speakers increased in 2022 compared with 2016 (p < 0.0001) but their overall representation was low with the highest proportion (25%) in the 2022 SCCM conference and the lowest (0.5%) in the 2017 ISICEM conference. This follow-up study demonstrates a narrowing but persisting gender gap in the studied critical care conferences. Thus, a commitment toward minimizing gender inequalities is warranted.","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140787596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of Setting the Tidal Volume Based on End-Expiratory Lung Volume: A Pilot Clinical Study: Erratum 根据呼气末肺活量设置潮气量的可行性:试点临床研究:勘误
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1097/CCE.0000000000001074
[This corrects the article DOI: 10.1097/CCE.0000000000001031.].
[此处更正了文章 DOI:10.1097/CCE.0000000000001031]。
{"title":"Feasibility of Setting the Tidal Volume Based on End-Expiratory Lung Volume: A Pilot Clinical Study: Erratum","authors":"","doi":"10.1097/CCE.0000000000001074","DOIUrl":"https://doi.org/10.1097/CCE.0000000000001074","url":null,"abstract":"[This corrects the article DOI: 10.1097/CCE.0000000000001031.].","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140774609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ketorolac Dosing and Outcomes in Neonates Following Congenital Heart Surgery: A Retrospective Analysis 先天性心脏病手术后新生儿的酮咯酸剂量和疗效:回顾性分析
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1097/CCE.0000000000001078
Amy L. Kiskaddon, Neil A. Goldenberg, Trent Abel, Jamie L. Fierstein, Delia Khayat, James A. Quintessenza, Arabela Stock
BACKGROUND: Pain management is essential for postoperative surgery. Given the association of opioids with adverse outcomes, interest in the use of nonopioid analgesics, such as ketorolac, has increased. Published data on use in neonates are limited. OBJECTIVES: To describe ketorolac dosing and safety and efficacy outcomes in the first 48 hours postcardiac surgery in neonates. DESIGN: We performed a single-center retrospective cohort study of neonates (ages < 28 d) who received ketorolac following cardiac surgery from November 2020 to July 2023 (inclusive). The primary safety outcome was a clinically significant decline in renal function, as defined by the composite of an increase in serum creatinine by greater than or equal to 0.3 mg/dL from baseline within 96 hours of ketorolac initiation and urine output less than or equal to 0.5 mL/kg/hr for 6 hours. The secondary safety outcome was clinically significant bleeding, defined as the composite of major bleeding by the International Society on Thrombosis and Hemostasis pediatric criteria and severe/fatal bleeding by the criteria of Nellis et al (2019). Efficacy was measured by opioid utilization based on a standardized pain score-driven analgesia protocol. INTERVENTIONS: Ketorolac was administered at 0.5 mg/kg every 6 hours as per an institutional clinical management algorithm. MEASUREMENTS AND MAIN RESULTS: Thirty-nine patients met the eligibility criteria. The median ketorolac dose was 0.5 mg/kg/dose, and median (interquartile range [IQR]) duration of therapy was 48 hours (6–48 hr). No patients experienced a significant decline in renal function, and there were no clinically significant bleeding events. The median (IQR) IV morphine milligram equivalents (MMEs)/kg/d of opioid administration was 0.2 MME/kg/d (0.1–0.25 MME/kg/d) at the time of ketorolac initiation and 0.1 MME/kg/d (0.1–0.2 MME/kg/d) at 48 hours post-ketorolac initiation. CONCLUSIONS: If validated prospectively, these findings suggest that a ketorolac regimen of 0.5 mg/kg/dose every 6 hours in neonates postcardiac surgery may be safe with regard to renal function and bleeding risk. Additional randomized studies would be needed to determine efficacy with regard to opioid-sparing capacity.
背景:疼痛管理是术后手术的关键。鉴于阿片类药物与不良后果之间的关联,人们对使用非阿片类镇痛药(如酮咯酸)的兴趣与日俱增。已公布的新生儿使用数据有限。目的描述酮咯酸在新生儿心脏手术后 48 小时内的剂量、安全性和疗效。设计:我们对 2020 年 11 月至 2023 年 7 月(含)期间接受心脏手术后酮咯酸治疗的新生儿(年龄小于 28 d)进行了单中心回顾性队列研究。主要安全性结果是肾功能临床显著下降,即在开始使用酮咯酸的 96 小时内,血清肌酐比基线升高大于或等于 0.3 mg/dL,且 6 小时内尿量小于或等于 0.5 mL/kg/hr。次要安全性结果为临床重大出血,即国际血栓与止血学会儿科标准中的大出血和 Nellis 等人标准(2019 年)中的严重/致命出血。疗效通过基于标准化疼痛评分驱动的镇痛方案的阿片类药物使用情况来衡量。干预:根据机构临床管理算法,每 6 小时给予 0.5 mg/kg 的酮咯酸。测量和主要结果:39 名患者符合资格标准。酮咯酸的中位剂量为 0.5 毫克/千克/剂量,中位(四分位数间距 [IQR])治疗时间为 48 小时(6-48 小时)。没有患者出现肾功能明显下降的情况,也没有发生临床意义重大的出血事件。开始使用酮咯酸时,静脉注射吗啡毫克当量(MMEs)/千克/天的中位数(IQR)为0.2 MMEs/千克/天(0.1-0.25 MMEs/千克/天),开始使用酮咯酸后48小时的中位数(IQR)为0.1 MMEs/千克/天(0.1-0.2 MMEs/千克/天)。结论:如果经过前瞻性验证,这些研究结果表明,对于心脏手术后的新生儿,每 6 小时服用 0.5 毫克/千克/次的酮咯酸治疗方案在肾功能和出血风险方面可能是安全的。还需要进行更多的随机研究,以确定阿片类药物的疗效。
{"title":"Ketorolac Dosing and Outcomes in Neonates Following Congenital Heart Surgery: A Retrospective Analysis","authors":"Amy L. Kiskaddon, Neil A. Goldenberg, Trent Abel, Jamie L. Fierstein, Delia Khayat, James A. Quintessenza, Arabela Stock","doi":"10.1097/CCE.0000000000001078","DOIUrl":"https://doi.org/10.1097/CCE.0000000000001078","url":null,"abstract":"BACKGROUND: Pain management is essential for postoperative surgery. Given the association of opioids with adverse outcomes, interest in the use of nonopioid analgesics, such as ketorolac, has increased. Published data on use in neonates are limited. OBJECTIVES: To describe ketorolac dosing and safety and efficacy outcomes in the first 48 hours postcardiac surgery in neonates. DESIGN: We performed a single-center retrospective cohort study of neonates (ages < 28 d) who received ketorolac following cardiac surgery from November 2020 to July 2023 (inclusive). The primary safety outcome was a clinically significant decline in renal function, as defined by the composite of an increase in serum creatinine by greater than or equal to 0.3 mg/dL from baseline within 96 hours of ketorolac initiation and urine output less than or equal to 0.5 mL/kg/hr for 6 hours. The secondary safety outcome was clinically significant bleeding, defined as the composite of major bleeding by the International Society on Thrombosis and Hemostasis pediatric criteria and severe/fatal bleeding by the criteria of Nellis et al (2019). Efficacy was measured by opioid utilization based on a standardized pain score-driven analgesia protocol. INTERVENTIONS: Ketorolac was administered at 0.5 mg/kg every 6 hours as per an institutional clinical management algorithm. MEASUREMENTS AND MAIN RESULTS: Thirty-nine patients met the eligibility criteria. The median ketorolac dose was 0.5 mg/kg/dose, and median (interquartile range [IQR]) duration of therapy was 48 hours (6–48 hr). No patients experienced a significant decline in renal function, and there were no clinically significant bleeding events. The median (IQR) IV morphine milligram equivalents (MMEs)/kg/d of opioid administration was 0.2 MME/kg/d (0.1–0.25 MME/kg/d) at the time of ketorolac initiation and 0.1 MME/kg/d (0.1–0.2 MME/kg/d) at 48 hours post-ketorolac initiation. CONCLUSIONS: If validated prospectively, these findings suggest that a ketorolac regimen of 0.5 mg/kg/dose every 6 hours in neonates postcardiac surgery may be safe with regard to renal function and bleeding risk. Additional randomized studies would be needed to determine efficacy with regard to opioid-sparing capacity.","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140769686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ransomware Cyberattack Associated With Cardiac Arrest Incidence and Outcomes at Untargeted, Adjacent Hospitals 勒索软件网络攻击与无目标的邻近医院的心脏骤停发生率和预后有关
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1097/CCE.0000000000001079
Thaidan T. Pham, Theoren M. Loo, A. Malhotra, Christopher A. Longhurst, Diana Hylton, C. Dameff, Jeffrey Tully, Gabriel Wardi, Rebecca E. Sell, A. Pearce
OBJECTIVES: Healthcare ransomware cyberattacks have been associated with major regional hospital disruptions, but data reporting patient-oriented outcomes in critical conditions such as cardiac arrest (CA) are limited. This study examined the CA incidence and outcomes of untargeted hospitals adjacent to a ransomware-infected healthcare delivery organization (HDO). DESIGN, SETTING, AND PATIENTS: This cohort study compared the CA incidence and outcomes of two untargeted academic hospitals adjacent to an HDO under a ransomware cyberattack during the pre-attack (April 3–30, 2021), attack (May 1–28, 2021), and post-attack (May 29, 2021–June 25, 2021) phases. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Emergency department and hospital mean daily census, number of CAs, mean daily CA incidence per 1,000 admissions, return of spontaneous circulation, survival to discharge, and survival with favorable neurologic outcome were measured. The study evaluated 78 total CAs: 44 out-of-hospital CAs (OHCAs) and 34 in-hospital CAs. The number of total CAs increased from the pre-attack to attack phase (21 vs. 38; p = 0.03), followed by a decrease in the post-attack phase (38 vs. 19; p = 0.01). The number of total CAs exceeded the cyberattack month forecast (May 2021: 41 observed vs. 27 forecasted cases; 95% CI, 17.0–37.4). OHCA cases also exceeded the forecast (May 2021: 24 observed vs. 12 forecasted cases; 95% CI, 6.0–18.8). Survival with favorable neurologic outcome rates for all CAs decreased, driven by increases in OHCA mortality: survival with favorable neurologic rates for OHCAs decreased from the pre-attack phase to attack phase (40.0% vs. 4.5%; p = 0.02) followed by an increase in the post-attack phase (4.5% vs. 41.2%; p = 0.01). CONCLUSIONS: Untargeted hospitals adjacent to ransomware-infected HDOs may see worse outcomes for patients suffering from OHCA. These findings highlight the critical need for cybersecurity disaster planning and resiliency.
目的:医疗勒索软件网络攻击与主要的区域性医院中断有关,但报告心脏骤停(CA)等危急情况下以患者为导向的结果的数据却很有限。本研究调查了邻近受勒索软件感染的医疗机构(HDO)的非目标医院的心脏骤停发生率和结果。设计、环境和患者:这项队列研究比较了在勒索软件网络攻击前(2021 年 4 月 3 日至 30 日)、攻击中(2021 年 5 月 1 日至 28 日)和攻击后(2021 年 5 月 29 日至 2021 年 6 月 25 日)阶段,与受到勒索软件网络攻击的医疗保健提供机构相邻的两家非目标学术医院的 CA 发生率和结果。干预措施:无。测量和主要结果:测量了急诊科和医院的日平均收治人数、CA 数量、每千名入院患者的日平均 CA 发生率、自发性循环恢复情况、出院存活率和神经系统良好的存活率。研究共评估了 78 例 CA:其中院外 CA 44 例,院内 CA 34 例。从发病前到发病阶段,CA总数有所增加(21 vs. 38; p = 0.03),发病后则有所减少(38 vs. 19; p = 0.01)。CA 总数超过了网络攻击月的预测(2021 年 5 月:41 例观察病例 vs. 27 例预测病例;95% CI,17.0-37.4)。OHCA 病例数也超过了预测(2021 年 5 月:24 例观察病例与 12 例预测病例;95% CI,6.0-18.8)。受 OHCA 死亡率增加的影响,所有 CA 的良好神经功能结果存活率均有所下降:OHCA 的良好神经功能结果存活率从攻击前阶段到攻击阶段有所下降(40.0% vs. 4.5%;P = 0.02),随后在攻击后阶段有所上升(4.5% vs. 41.2%;P = 0.01)。结论:邻近受勒索软件感染的 HDO 的非目标医院可能会导致 OHCA 患者的预后更差。这些发现凸显了对网络安全灾难规划和恢复能力的迫切需要。
{"title":"Ransomware Cyberattack Associated With Cardiac Arrest Incidence and Outcomes at Untargeted, Adjacent Hospitals","authors":"Thaidan T. Pham, Theoren M. Loo, A. Malhotra, Christopher A. Longhurst, Diana Hylton, C. Dameff, Jeffrey Tully, Gabriel Wardi, Rebecca E. Sell, A. Pearce","doi":"10.1097/CCE.0000000000001079","DOIUrl":"https://doi.org/10.1097/CCE.0000000000001079","url":null,"abstract":"OBJECTIVES: Healthcare ransomware cyberattacks have been associated with major regional hospital disruptions, but data reporting patient-oriented outcomes in critical conditions such as cardiac arrest (CA) are limited. This study examined the CA incidence and outcomes of untargeted hospitals adjacent to a ransomware-infected healthcare delivery organization (HDO). DESIGN, SETTING, AND PATIENTS: This cohort study compared the CA incidence and outcomes of two untargeted academic hospitals adjacent to an HDO under a ransomware cyberattack during the pre-attack (April 3–30, 2021), attack (May 1–28, 2021), and post-attack (May 29, 2021–June 25, 2021) phases. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Emergency department and hospital mean daily census, number of CAs, mean daily CA incidence per 1,000 admissions, return of spontaneous circulation, survival to discharge, and survival with favorable neurologic outcome were measured. The study evaluated 78 total CAs: 44 out-of-hospital CAs (OHCAs) and 34 in-hospital CAs. The number of total CAs increased from the pre-attack to attack phase (21 vs. 38; p = 0.03), followed by a decrease in the post-attack phase (38 vs. 19; p = 0.01). The number of total CAs exceeded the cyberattack month forecast (May 2021: 41 observed vs. 27 forecasted cases; 95% CI, 17.0–37.4). OHCA cases also exceeded the forecast (May 2021: 24 observed vs. 12 forecasted cases; 95% CI, 6.0–18.8). Survival with favorable neurologic outcome rates for all CAs decreased, driven by increases in OHCA mortality: survival with favorable neurologic rates for OHCAs decreased from the pre-attack phase to attack phase (40.0% vs. 4.5%; p = 0.02) followed by an increase in the post-attack phase (4.5% vs. 41.2%; p = 0.01). CONCLUSIONS: Untargeted hospitals adjacent to ransomware-infected HDOs may see worse outcomes for patients suffering from OHCA. These findings highlight the critical need for cybersecurity disaster planning and resiliency.","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140790781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Critical care explorations
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1